UK Markets open in 7 mins

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.70-0.07 (-1.21%)
At close: 04:00PM EDT
5.74 +0.04 (+0.70%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-53.99%
S&P500 52-week change 3-16.45%
52-week high 317.85
52-week low 32.87
50-day moving average 35.84
200-day moving average 35.70

Share statistics

Avg vol (3-month) 38.18M
Avg vol (10-day) 312.18M
Shares outstanding 577.12M
Implied shares outstanding 6N/A
Float 866.61M
% held by insiders 11.17%
% held by institutions 167.80%
Shares short (30 Aug 2022) 419.74M
Short ratio (30 Aug 2022) 42.04
Short % of float (30 Aug 2022) 435.10%
Short % of shares outstanding (30 Aug 2022) 425.60%
Shares short (prior month 28 Jul 2022) 415.19M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21544:1000
Last split date 304 Nov 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 0.00%
Operating margin (ttm)-7,906.34%

Management effectiveness

Return on assets (ttm)-29.67%
Return on equity (ttm)-87.14%

Income statement

Revenue (ttm)6.09M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)962.20%
Gross profit (ttm)-351.14M
EBITDA -484.96M
Net income avi to common (ttm)-507.45M
Diluted EPS (ttm)-10.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)132.51M
Total cash per share (mrq)1.72
Total debt (mrq)292.97M
Total debt/equity (mrq)162.65
Current ratio (mrq)1.12
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-506.32M
Levered free cash flow (ttm)-366.52M